Streetbeat News

Products Services

LLY

NVO

The high demand for GLP-1 medications like Ozempic and Zepbound for weight loss is causing shortages, leaving type 2 diabetic patients without access to these critical drugs. This surge is driven by social media and off-label use, impacting companies like Novo Nordisk and Eli Lilly.

Portfolio Pulse from Vandana Singh

July 19, 2024 | 5:32 pm

CMA

CRWD

MSTR

SPY

TLT

Wall Street is experiencing its worst week in three months, driven by a tech sector falter due to a cloud software update from CrowdStrike Holdings Inc. (CRWD). Major indices like the S&P 500, Nasdaq 100, and Dow Jones are all down. Treasury yields are rising, oil prices are falling, and Bitcoin is rallying. Key stock movers include CRWD, CMA, HE, and several others.

Portfolio Pulse from Piero Cingari

July 19, 2024 | 5:27 pm

LMT

The Pentagon has accepted the first F-35 of new deliveries on Friday, marking a significant milestone for the F-35 program.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 5:18 pm

META

Meta Platforms Inc (NASDAQ:META) is advancing with its VR and AR hardware plans despite layoffs in its Reality Labs division. The company aims to release the Quest 4 in 2026 and a higher-end headset in 2027. Meta is also working on AR glasses, though they face significant design challenges.

Portfolio Pulse from Franca Quarneti

July 19, 2024 | 5:18 pm

CRWD

MSFT

TSLA

Tesla halted some of its production lines due to an IT outage involving Microsoft and CrowdStrike.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 5:13 pm

AMD

ARM

NVDA

TSM

ARM Holdings Plc (NASDAQ:ARM) shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $107 to $190. The broader semiconductor sector has seen a selloff due to geopolitical tensions and U.S. sanctions against China. ARM's CEO announced plans for AI-ready devices by 2025, and the company has strong licensing and royalty potential. ARM's architecture is favored for its efficiency, with major clients including Apple, Amazon, Google, Microsoft, Nvidia, and Qualcomm.

Portfolio Pulse from Anusuya Lahiri

July 19, 2024 | 5:12 pm

CVX

Benzinga's options scanner detected significant options trading activity for Chevron (NYSE:CVX), with a total amount of $309,250 in trades. Whales have been targeting a price range of $150.0 to $170.0 for Chevron over the last 3 months. The largest options trades observed were predominantly bullish, with calls and puts indicating a positive sentiment. Chevron's current trading volume is 2,426,089, with the stock price at $160.66, down by -0.81%. Earnings announcement is expected in 14 days.

Portfolio Pulse from Benzinga Insights

July 19, 2024 | 5:01 pm

CRWD

MSFT

Goldman Sachs analyst Gabriela Borges maintains a Buy rating on CrowdStrike (CRWD) despite a significant outage caused by a failed update on its Falcon platform. The outage affected Microsoft (MSFT) systems globally. Borges expects CrowdStrike's strong reputation to aid recovery and projects fiscal 2025 revenue and EPS of $4 billion and $4.02, respectively.

Portfolio Pulse from Anusuya Lahiri

July 19, 2024 | 5:00 pm

CRWD

CrowdStrike Holdings, Inc. (NASDAQ:CRWD) experienced a significant stock drop due to a cybersecurity platform issue causing worldwide IT outages. Despite the decline, the stock shows technical support at previous low levels, indicating potential buy interest from remorseful sellers.

Portfolio Pulse from Mark Putrino

July 19, 2024 | 4:37 pm

SBUX

Starbucks is experiencing impacts due to a widespread third-party systems outage, according to Reuters.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 4:37 pm